Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 (eEF1A1)

Target
eEF1A1
Molecular classification
Enzyme, Translation elongation factor, GTPase, Other
01

Overview

Eukaryotic translation elongation factor 1 alpha 1 (eEF1A1) is a highly conserved GTPase and a key component of the protein synthesis machinery in eukaryotes. It catalyzes the GTP-dependent binding of aminoacyl-tRNA to the A-site of the ribosome during the elongation phase of translation[1][6]. Beyond its canonical role, eEF1A1 regulates the actin cytoskeleton, participates in targeting misfolded proteins for degradation, acts as a coactivator of certain receptors, and contributes to stress response and heat shock protein induction[1][2][3]. eEF1A1 is involved in viral replication and has a documented role as an autoantigen in some autoimmune diseases, while its dysregulation has been implicated in cancer and in resistance to apoptosis[1][3]. Therapeutic targeting is theoretically possible but is complicated by its central cellular functions and safety concerns.

Other names
Elongation factor 1-alpha 1EF-1αTranslation elongation factor EF-1 alphaEEF1A1
02

Mechanism of action

Inhibition or modulation of aminoacyl-tRNA binding, Interference with GTPase activity, Inhibition of translation elongation

03

Biological functions

Protein synthesis (translation)Aminoacyl-tRNA deliveryCytoskeletal regulationApoptosis regulationProtein degradationViral replicationStress response
04

Disease associations

CancerInfectionAutoimmune disease (e.g., Felty's syndrome)Other
05

Safety considerations

Essential for general protein synthesis—systemic inhibition may cause cytotoxicitynon-selectivity may affect healthy cellspotential role in resistance to apoptosis in transformed cells
06

Biomarkers

Autoantigen in Felty's syndromeProtein expression as marker in some cancers

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 (eEF1A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 (eEF1A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call